Aggrenox Plaintiffs Say Boehringer's Lidoderm Take Is Wrong
Drugstore chains accusing Boehringer Ingelheim Pharmaceuticals Inc. of scheming to keep generic versions of the stroke drug Aggrenox off the market shot back at the defendants' arguments that a recent ruling...To view the full article, register now.
Already a subscriber? Click here to view full article